SEC Form 3 filed by CollPlant Biotechnologies Ltd
3 - CollPlant Biotechnologies Ltd (0001631487) (Issuer)
- SEC Form 4 filed by Safehold Inc. New
4 - Safehold Inc. (0001095651) (Issuer)
- SEC Form 4 filed by NovaBridge Biosciences
4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by Quince Therapeutics Inc.
3 - IRulya Therapeutics Inc. (0001662774) (Issuer)
- SEC Form 3 filed by CG Oncology Inc.
3 - CG Oncology, Inc. (0001991792) (Issuer)
- SEC Form 3 filed by Quince Therapeutics Inc.
3 - IRulya Therapeutics Inc. (0001662774) (Issuer)
- SEC Form 4 filed by Helmerich & Payne Inc.
4 - Helmerich & Payne, Inc. (0000046765) (Issuer)
- SEC Form 3 filed by Hain Celestial Group Inc.
3 - HAIN CELESTIAL GROUP INC (0000910406) (Issuer)
- SEC Form 3 filed by Quince Therapeutics Inc.
3 - IRulya Therapeutics Inc. (0001662774) (Issuer)
- FIRST UNITED CORPORATION ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
OAKLAND, Md., Oct. 19, 2026 /PRNewswire/ -- First United Corporation (the "Corporation", "we", "us", and "our") (NASDAQ:FUNC), a bank holding company and the parent company of First United Bank & Trust (the "Bank"), today announced financial results for the three- and nine-month periods ended September 30, 2026. Consolidated net income was $7.2 million on a Generally Accepted Accounting Principles ("GAAP") basis for the third quarter of 2026, or $1.11 per diluted share, compared to $6.9 million, or $1.07 per diluted share, for the third quarter of 2025 and $5.7 million, or $0.88 per diluted share, for the second quarter of 2026. Net income for the first nine months of 2026 was $19.5 millio
- Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026
DUBLIN, Oct. 19, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced it will report its 2026 third quarter financial results on Monday, November 2, 2026, after the close of the U.S. financial markets. Company management will host a webcast at 4:30 p.m. ET to discuss the results and provide a business and financial update.Interested parties may register for the call in advance here or via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.A replay of the webcast will be available via the Investors section
- Heritage Announces Third Quarter 2026 Earnings Dates
TAMPA, Fla., Oct. 19, 2026 /PRNewswire/ -- Heritage Insurance Holdings, Inc. (NYSE:HRTG) ("Heritage" or the "Company"), a super-regional property and casualty insurance holding company, will announce its third quarter 2026 financial results after the market close on Wednesday, October 28, 2026, followed by a 9:00am ET conference call on Thursday, October 29, 2026. Conference Call Details:North American Dial-in: 1-888-346-3095International Dial-in: 1-412-902-4258Telephone participants should ask to be joined into the Heritage Insurance Holdings Third Quarter 2026 Earnings Call.Webcast:A live audio webcast of the earnings call will be available in the investors section of the Company's web
- SEC Form 4 filed by Willis Towers Watson Public Limited Company
4 - WILLIS TOWERS WATSON PLC (0001140536) (Issuer)
- SEC Form 3 filed by Quince Therapeutics Inc.
3 - IRulya Therapeutics Inc. (0001662774) (Issuer)
- Metropolitan Bank Holding Corp. Declares Increased Quarterly Common Stock Cash Dividend
Metropolitan Bank Holding Corp. (the "Company") (NYSE:MCB), the holding company for Metropolitan Commercial Bank, today announced a quarterly cash dividend of $0.40 per share on the Company’s common stock (the "Dividend"), an increase of $0.05 from the prior quarterly dividend of $0.35 per share. The Dividend is payable on November 10, 2026 to holders of record of the Company’s common stock at the close of business on October 30, 2026. About Metropolitan Bank Holding Corp. Metropolitan Bank Holding Corp., the holding company for Metropolitan Commercial Bank ("MCB") is a New York City–based, full-service commercial bank serving businesses, institutions, and individuals who value expertis
- Fabrinet to Announce First Quarter Fiscal Year 2027 Financial Results on November 2, 2026
BANGKOK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Fabrinet (NYSE:FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release financial results for the first quarter of fiscal year 2027, which ended September 25, 2026, after market close on Monday, November 2, 2026. On that day, management will hold a conference call and webcast at 5:00 p.m. EDT to review and discuss the Company’s results. What:Fabrinet First Quarter Fiscal Year 2027 Financial Results CallWhen:Monday, November 2, 2026Time:5:00 p.m. EDTLive Call & Replay:https://investor.